Journal
CELL
Volume 161, Issue 1, Pages 161-172Publisher
CELL PRESS
DOI: 10.1016/j.cell.2015.01.036
Keywords
-
Categories
Funding
- NIH [HL-20948]
- Perot Foundation
- Moss Heart Foundation
- O'Donnell Foundation
Ask authors/readers for more resources
One-fourth of all deaths in industrialized countries result from coronary heart disease. A century of research has revealed the essential causative agent: cholesterol-carrying low-density lipoprotein (LDL). LDL is controlled by specific receptors (LDLRs) in liver that remove it from blood. Mutations that eliminate LDLRs raise LDL and cause heart attacks in childhood, whereas mutations that raise LDLRs reduce LDL and diminish heart attacks. If we are to eliminate coronary disease, lowering LDL should be the primary goal. Effective means to achieve this goal are currently available. The key questions are: who to treat, when to treat, and how long to treat.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available